VanEck Associates’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $194K | Buy |
3,286
+148
| +5% | +$8.74K | ﹤0.01% | 1251 |
|
|
2025
Q1 | $230K | Buy |
3,138
+204
| +7% | +$15K | ﹤0.01% | 1226 |
|
|
2024
Q4 | $243K | Sell |
2,934
-59,571
| -95% | -$4.93M | ﹤0.01% | 1210 |
|
|
2024
Q3 | $4.62M | Buy |
62,505
+16,583
| +36% | +$1.23M | 0.01% | 675 |
|
|
2024
Q2 | $3.15M | Buy |
45,922
+183
| +0.4% | +$12.5K | ﹤0.01% | 745 |
|
|
2024
Q1 | $2.45M | Buy |
45,739
+11,359
| +33% | +$609K | ﹤0.01% | 802 |
|
|
2023
Q4 | $1.83M | Buy |
34,380
+15,552
| +83% | +$829K | ﹤0.01% | 821 |
|
|
2023
Q3 | $935K | Buy |
18,828
+5,467
| +41% | +$271K | ﹤0.01% | 914 |
|
|
2023
Q2 | $796K | Buy |
13,361
+1,453
| +12% | +$86.6K | ﹤0.01% | 919 |
|
|
2023
Q1 | $674K | Buy |
11,908
+7,277
| +157% | +$412K | ﹤0.01% | 932 |
|
|
2022
Q4 | $344K | Buy |
4,631
+1,732
| +60% | +$129K | ﹤0.01% | 987 |
|
|
2022
Q3 | $173K | Buy |
2,899
+261
| +10% | +$15.6K | ﹤0.01% | 1057 |
|
|
2022
Q2 | $148K | Buy |
2,638
+645
| +32% | +$36.2K | ﹤0.01% | 1135 |
|
|
2022
Q1 | $147K | Sell |
1,993
-14,363
| -88% | -$1.06M | ﹤0.01% | 1159 |
|
|
2021
Q4 | $1.18M | Buy |
16,356
+2,485
| +18% | +$179K | ﹤0.01% | 817 |
|
|
2021
Q3 | $1.06M | Buy |
13,871
+12,917
| +1,354% | +$990K | ﹤0.01% | 798 |
|
|
2021
Q2 | $74K | Buy |
954
+548
| +135% | +$42.5K | ﹤0.01% | 1141 |
|
|
2021
Q1 | $25K | Buy |
+406
| New | +$25K | ﹤0.01% | 1163 |
|